Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Guerbet

Market Cap 116M 133M 108M 101M 189M 12.59B 190M 1.28B 495M 6.2B 501M 490M 21.51B P/E 2026 *
-259x
P/E 2027 * 5.73x
Enterprise Value 410M 470M 380M 355M 666M 44.35B 670M 4.5B 1.75B 21.83B 1.76B 1.73B 75.8B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.49x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.8%
1 day-0.67%
1 week-7.00%
Current month-10.82%
1 month-2.84%
3 months-2.41%
6 months-35.51%
Current year-36.88%
1 week 8.9
Extreme 8.9
9.61
1 month 8.9
Extreme 8.9
10.66
Current year 7.74
Extreme 7.74
14.92
1 year 7.74
Extreme 7.74
23.6
3 years 7.74
Extreme 7.74
39.4
5 years 7.74
Extreme 7.74
43.65
10 years 7.74
Extreme 7.74
89.68
Manager TitleAgeSince
Chief Executive Officer - 2026-02-01
Chief Executive Officer - 2025-09-21
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 2015-05-28
Director/Board Member 49 2017-05-18
Director/Board Member 51 2023-11-21
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-7.00% - - 133M
-5.99%-9.24%-19.45%-24.47% 12.54B
-0.26%+7.72%+93.53%+22.87% 5.27B
-1.04%-3.45%-36.22%-65.08% 1.21B
+1.69%-0.95%-32.67%-43.30% 1.19B
+1.22%-1.50%+58.31%+92.56% 1.18B
-0.53%-3.60%-37.73% - 949M
-5.27%-1.71%+213.40%+194.59% 704M
+1.69%-8.07% - - 330M
-0.74%-0.55%-57.45%+200.00% 247M
Average -0.99%-2.23%+22.71%+53.88% 2.62B
Weighted average by Cap. -3.29%-3.88%+14.39%-0.94%

Financials

2026 *2027 *
Net sales 754M 865M 698M 654M 1.23B 81.57B 1.23B 8.28B 3.21B 40.15B 3.25B 3.18B 139B 796M 913M 737M 690M 1.29B 86.16B 1.3B 8.75B 3.39B 42.41B 3.43B 3.35B 147B
Net income -1.62M -1.85M -1.5M -1.4M -2.63M -175M -2.65M -17.77M -6.89M -86.14M -6.96M -6.81M -299M 29.08M 33.35M 26.93M 25.21M 47.28M 3.15B 47.57M 320M 124M 1.55B 125M 123M 5.38B
Net Debt 294M 337M 272M 254M 477M 31.77B 480M 3.23B 1.25B 15.64B 1.26B 1.24B 54.29B 277M 318M 257M 240M 451M 30.02B 454M 3.05B 1.18B 14.77B 1.19B 1.17B 51.3B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change
26-06-19 8.900 -0.67%
26-06-18 8.960 -0.78%
26-06-17 9.030 -3.63%
26-06-16 9.370 -2.50%
26-06-15 9.610 +0.42%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
9.220EUR
Average target price
11.60EUR
Spread / Average Target
+25.81%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!